Elion Raises $9.3M to Bring Structure to Health Tech Decisions

In a year marked by aggressive AI adoption and ballooning vendor lists across healthcare systems, Bobby Guelich saw a widening gap in the decision-making processes meant to govern technology. “Today, selecting the right technology has never mattered more,” Guelich wrote in a LinkedIn post. “AI is transforming healthcare, and the organizations that can identify and adopt the right solutions will be the ones that thrive, while those that can’t risk falling behind operationally, financially, and clinically.”

Guelich, CEO of Elion, believes health systems are overwhelmed by choice. New tools promise everything from administrative automation to clinical intelligence, yet few institutions have the internal research capacity or structured data to effectively evaluate them. Elion looks to be a platform to help healthcare leaders cut through the vendor noise and make faster, smarter procurement decisions.

The company recently raised $9.3 million in seed funding to scale its efforts. The round was led by NEA, with participation from Cedars Sinai Health Ventures, TMV, Scrub Capital, and Alumni Ventures. According to Guelich, Elion already serves more than 60% of U.S. health systems and has seen a fivefold increase in usage over the past year.

Vendor Intelligence for an Unstructured Market

Elion operates as a health IT marketplace and research firm. Its core product is a structured dataset tracking thousands of health technology vendors. Unlike generic procurement databases, Elion incorporates domain expertise from healthcare operations and system-level workflows to contextualize product performance and relevance. In theory, this shortens the evaluation cycle and reduces the risk of adopting low-fit tools in a high-stakes environment.